Comparison of Clinical Outcomes and Imaging Features in Hospitalized Patients with SARS-CoV-2 Omicron Subvariants
- 1 July 2023
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 308 (1) , e230653
Abstract
Background Differences in the clinical and radiological characteristics of SARS-CoV-2 Omicron subvariants have not been well studied. Purpose To compare clinical disease severity and radiologically severe pneumonia in patients with COVID-19 hospitalized during a period of either Omicron BA.1/BA.2 or Omicron BA.5 subvariant predominance. Materials and Methods This multicenter retrospective study, included patients registered in the Korean Imaging Cohort of COVID-19 database who were hospitalized for COVID-19 between January and December 2022. Publicly available relative variant genome frequency data were used to determine the dominant periods of Omicron BA.1/BA.2 subvariants (January 17 to June 20, 2022) and the Omicron BA.5 subvariant (July 4 to December 5, 2022). Clinical outcomes and imaging pneumonia outcomes based on chest radiography and CT were compared among predominant subvariants using multivariable analyses adjusted for covariates. Results Of 1916 confirmed patients with COVID-19 (mean age, 72 years ± 16 [SD]; 1019 males), 1269 were registered during the Omicron BA.1/BA.2 subvariant dominant period and 647 during the Omicron BA.5 subvariant dominant period. Patients in the BA.5 group showed lower odds of high-flow O2 requirement (adjusted odds ratio [OR], 0.75 [95% CI: 0.57, 0.99]; P = .04), mechanical ventilation (adjusted OR, 0.49 [95% CI: 0.34, 0.72]; P < .001]), and death (adjusted OR, 0.47 [95% CI: 0.33, 0.68]; P <.001) than those in the BA.1/BA.2 group. Additionally, the BA.5 group had lower odds of severe pneumonia on chest radiographs (adjusted OR, 0.68 [95% CI: 0.53, 0.88]; P = .004) and higher odds of atypical pattern pneumonia on CT images (adjusted OR, 1.81 [95% CI: 1.26, 2.58]; P = .001) than the BA.1/BA.2 group. Conclusions Patients hospitalized during the period of Omicron BA.5 subvariant predominance had lower odds of clinical and pneumonia severity than those hospitalized during the period of Omicron BA.1/BA.2 predominance, even after adjusting for covariates. See also the editorial by Hammer in this issue.Keywords
This publication has 21 references indexed in Scilit:
- Secondary Attack Rates for Omicron and Delta Variants of SARS-CoV-2 in Norwegian HouseholdsJAMA, 2022
- Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants — United States, June 2021–January 2022MMWR. Morbidity and Mortality Weekly Report, 2022
- Imaging and Clinical Features of COVID-19 Breakthrough Infections: A Multicenter StudyRadiology, 2022
- Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodiesNature, 2021
- Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease SeverityJAMA, 2021
- Chest Radiograph Scoring Alone or Combined with Other Risk Scores for Predicting Outcomes in COVID-19Radiology, 2021
- COVID-19 pneumonia: Diagnostic and prognostic role of CT based on a retrospective analysis of 214 consecutive patients from Paris, FranceEuropean Journal of Radiology, 2020
- KSR/KSTR Guidelines for the Use of Diagnostic Imaging for COVID-19Journal of the Korean Society of Radiology, 2020
- Radiological Society of North America Expert Consensus Document on Reporting Chest CT Findings Related to COVID-19: Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNARadiology: Cardiothoracic Imaging, 2020
- Establishment of a Nationwide Korean Imaging Cohort of Coronavirus Disease 2019Journal of Korean Medical Science, 2020